These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10573477)

  • 61. Nephrotic syndrome and Guillan-Barré Syndrome: a rare association in child.
    Bouyahia O; Khelifi I; Gharsallah L; Harzallah K; Mrad SM; Ghargah T; Boukthir S; Azza Sel G
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):135-7. PubMed ID: 20061709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retinal vein occlusion following intravenous immunoglobulin treatment.
    Nawasiwatte BM; Somaratne SC; Fernando A; Gunaratne PS
    Ceylon Med J; 2012 Dec; 57(4):170-1. PubMed ID: 23292061
    [No Abstract]   [Full Text] [Related]  

  • 64. Parechovirus infection preceding Guillain-Barré syndrome.
    Linden S; Vuorinen T; Österback R; Soilu-Hänninen M
    J Neurovirol; 2012 Oct; 18(5):434-6. PubMed ID: 22581426
    [No Abstract]   [Full Text] [Related]  

  • 65. Anaphylaxis with intravenous immunoglobulin: a time for introspection.
    Jain RS; Agrawal R; Kumar S; Gupta PK
    Am J Emerg Med; 2015 Sep; 33(9):1332.e1-2. PubMed ID: 25819200
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment of Guillain-Barré syndrome.
    McNair ND
    J Infus Nurs; 2013; 36(6):397-400. PubMed ID: 24202119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A rare form of Guillain-Barré syndrome: pharyngeal-cervical-brachial variant.
    Hergüner MO; Tepe T; Altunbaşak S; Baytok V
    Turk J Pediatr; 2008; 50(1):91-3. PubMed ID: 18365602
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Acute polyradiculoneuropathy. Guillain-Barre syndrome].
    Turki I; Djaïet S; Boukhris S; Hentati F
    Tunis Med; 2003 Oct; 81(10):781-7. PubMed ID: 17722794
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Guillain-Barré syndrome in a child with normal tendon reflexes].
    Tellier S; Gerdelat-Mas A; Karsenty C; Cancès C; Tison C; Chaix Y; Cheuret E
    Arch Pediatr; 2012 Jan; 19(1):51-4. PubMed ID: 22154102
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Guillain-Barré syndrome in elderly people.
    Leung SS
    J Am Geriatr Soc; 2008 Feb; 56(2):381-2. PubMed ID: 18251836
    [No Abstract]   [Full Text] [Related]  

  • 72. 'Hyperacute' Guillain-Barré syndrome.
    Steiner I; Wirguin I; Blumen SC; Dano M; Raphaeli G; Schwartz I; Korn-Lubetzki I
    Eur Neurol; 2008; 59(1-2):88-90. PubMed ID: 17934279
    [No Abstract]   [Full Text] [Related]  

  • 73. Unraveling Guillain-Barré syndrome.
    Castro MC
    Nurs Manage; 2010 Aug; 41(8):36-9; quiz 39-40. PubMed ID: 20671533
    [No Abstract]   [Full Text] [Related]  

  • 74. Is a second cycle of immunoglobulin justified in axonal forms of Guillain-Barré syndrome?
    Godoy DA; Rabinstein A
    Arq Neuropsiquiatr; 2015 Oct; 73(10):848-51. PubMed ID: 26465402
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Miller Fisher variant of Guillain-Barré syndrome masquerading as acute sphenoid sinusitis with orbital apex syndrome.
    Chaudhary A; Ramchand T; Frohman LP; Liu JK; Eloy JA
    Laryngoscope; 2012 May; 122(5):970-2. PubMed ID: 22447677
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
    Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
    Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiple complications of IVIG therapy in a patient with Guillain-Barré syndrome.
    Steinberger B; Coleman TA
    Am J Hematol; 2001 May; 67(1):59. PubMed ID: 11279662
    [No Abstract]   [Full Text] [Related]  

  • 78. Is a second course of intravenous immunoglobulin treatment in Guillain-Barré syndrome justifiable?
    Yang J; Jia R
    J Clin Neurosci; 2020 Jul; 77():251-252. PubMed ID: 32362471
    [No Abstract]   [Full Text] [Related]  

  • 79. [Immunoglobulin therapy for neurologic diseases].
    Nomura K
    Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):2046-53. PubMed ID: 17929453
    [No Abstract]   [Full Text] [Related]  

  • 80. Vagus nerve stimulation and drug reduction.
    Venkataraman V
    Neurology; 2001 Sep; 57(5):938-9. PubMed ID: 11552043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.